Cancer Research Grants  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4014-4022, September 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Studzinski, G. P.
Right arrow Articles by Moore, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Studzinski, G. P.
Right arrow Articles by Moore, D. C.

Sunlight—Can It Prevent as well as Cause Cancer?1

George P. Studzinski2 and Dorothy C. Moore

Department of Laboratory Medicine and Pathology, UMD-New Jersey Medical School, Newark, New Jersey 07103

Excessive exposure to sunlight is known to damage the skin. However, the emphasis of most studies has been on the consequences of sunlight exposure to fair-skinned individuals, and the situation of people with heavy skin pigmentation residing in, or migrating to, geographic locations with limited sunlight incidence has been largely neglected. Recent epidemiological studies suggested the hypothesis that sunlight deprivation, and the associated reduction in the circulating levels of vitamin D3 (vit D3) derivatives may lead to the increased incidence of the carcinomas of the breast, colon, and prostate. Two endocrine pathways may mediate these effects. The pineal function can potentially be involved, but the formation of vit D3 derivatives is gaining credibility as a mechanism for the retardation of cancer progression. Evidence is accumulating that such compounds, e.g., 1,25-dihydroxyvitamin D3 (1,25D3) induce differentiation of several neoplastic cell types, arrest or retard their proliferation, and act as chemopreventive agents in animal carcinogenesis. We also propose that the antineoplastic effects of vit D3 derivatives are exerted at several steps in tumor progression and that immunomodulating effects of 1,25D3 may contribute to these effects of sunlight. The recent findings that common cancers, e.g., carcinoma of the prostate and the breast, behave more aggressively in black Americans than in white Americans may be explained on this basis. Although more data are needed on the effects of sunlight on the circulating levels of 1,25D3, a corollary of this hypothesis is that there should be no broad condemnation of moderate sunlight exposure, as it may be available in insufficient amounts to some Americans.

1 Supported by USPHS Grants RO1-CA44722 and R29-DK45270.

2 To whom requests for reprints should be addressed, at Department of Laboratory Medicine and Pathology, UMD-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103.

Received 4/20/95. Accepted 7/19/95.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q.-P. Li, X. Qi, R. Pramanik, N. M. Pohl, M. Loesch, and G. Chen
Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity
J. Biol. Chem., January 19, 2007; 282(3): 1544 - 1551.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Giovannucci, Y. Liu, and W. C. Willett
Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2467 - 2472.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Cui and T. E. Rohan
Vitamin d, calcium, and breast cancer risk: a review.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. G. Schwartz and W. J. Blot
Vitamin d status and cancer incidence and mortality: something new under the sun.
J Natl Cancer Inst, April 5, 2006; 98(7): 428 - 430.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Bodiwala, C. J. Luscombe, M. E. French, S. Liu, M. F. Saxby, P. W. Jones, S. Ramachandran, A. A. Fryer, and R. C. Strange
Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type
Carcinogenesis, April 1, 2003; 24(4): 711 - 717.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski
Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium
Cancer Res., March 15, 2003; 63(6): 1325 - 1332.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. J. Luscombe, M. E. French, S. Liu, M. F. Saxby, P. W. Jones, A. A. Fryer, and R. C. Strange
Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes
Carcinogenesis, September 1, 2001; 22(9): 1343 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. M. Maas, K. Reus, B. Diesel, W.-I. Steudel, W. Feiden, U. Fischer, and E. Meese
Amplification and Expression of Splice Variants of the Gene Encoding the P450 Cytochrome 25-Hydroxyvitamin D3 1,{{alpha}}-Hydroxylase (CYP 27B1) in Human Malignant Glioma
Clin. Cancer Res., April 1, 2001; 7(4): 868 - 875.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
R. Koren, I. Hadari-Naor, E. Zuck, C. Rotem, U. A. Liberman, and A. Ravid
Vitamin D Is a Prooxidant in Breast Cancer Cells
Cancer Res., February 1, 2001; 61(4): 1439 - 1444.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Slominski and J. Wortsman
Neuroendocrinology of the Skin
Endocr. Rev., October 1, 2000; 21(5): 457 - 487.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
P. A. Hershberger, R. A. Modzelewski, Z. R. Shurin, R. M. Rueger, D. L. Trump, and C. S. Johnson
1,25-Dihydroxycholecalciferol (1,25-D3) Inhibits the Growth of Squamous Cell Carcinoma and Down-Modulates p21Waf1/Cip1 in Vitro and in Vivo
Cancer Res., June 1, 1999; 59(11): 2644 - 2649.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ravid, D. Rocker, A. Machlenkin, C. Rotem, A. Hochman, G. Kessler-Icekson, U. A. Liberman, and R. Koren
1,25-Dihydroxyvitamin D3 Enhances the Susceptibility of Breast Cancer Cells to Doxorubicin-induced Oxidative Damage
Cancer Res., February 1, 1999; 59(4): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. J. Van schooten, A. Hirvonen, L. M. Maas, B. A. De mol, J. C. S. kleinjans, D. A. Bell, and J. D. Durrer
Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue
FASEB J, October 1, 1998; 12(13): 1409 - 1417.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.